Healthy Dialogue
Healthy Dialogue
JAMA Network
Cost-effectiveness of Varying 10-Year Risk Statin Treatment Thresholds
14 minutes Posted Jul 14, 2015 at 3:00 pm.
0:00
14:27
Download MP3
Show notes

Interview with Thomas A. Gaziano, MD, MSc, author of Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease